Ropes & Gray represented Cullinan Oncology in the deal. Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan...
Cullinan Oncology’s Collaboration with Taiho Pharmaceutical
SmartLabs’ $250 Million Series B Financing
Ropes & Gray represented SmartLabs in the transaction. SmartLabs, a Boston-based Laboratory-as-a-Service leader, raised $250 million in a Series B financing that will be used to help...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...
Bain Capital Tech Opportunities’ $150 Million Investment in Axtria
Ropes & Gray advised Bain Capital Tech Opportunities in the transaction. Bain Capital Tech Opportunities executed its $150 million investment in Axtria, a global cloud software...
NeoGenomics’ Acquisition of Inivata
Ropes & Gray advised NeoGenomics on the deal. NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, executed its...
Cornell Capital and Trilantic North America’s Acquisition of Fastaff and U.S. Nursing
Davis Polk & Wardwell LLP advised Cornell Capital, Kirkland & Ellis LLP advised Trilantic North America, and Ropes & Gray LLP advised Thomas H. Lee Partners,...






























